StockDriftsStockDriftsTop 50 Sofinnova Investments INC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| NTRA | Natera Inc | 15.53% | 1.55M | $310.0M | +0.00%(+0) | $9.21(+2932.81%) | 2026-03-31 | |
| BMY | Bristol-Myers Squibb Co | 6.04% | 1.99M | $120.6M | +31.44%(+475.73K) | $53.11(+9.45%) | 2026-03-31 | |
| JAZZ | Jazz Pharmaceuticals PLC | 5.67% | 598.3K | $113.1M | -37.67%(-361.53K) | $128.49(+89.48%) | 2026-03-31 | |
| VERA | Vera Therapeutics Inc | 5.63% | 2.79M | $112.4M | +0.00%(+0) | $14.20(+190.24%) | 2026-03-31 | |
| UTHR | United Therapeutics Corp | 4.76% | 160.1K | $94.9M | +1.54%(+2.43K) | $321.75(+72.77%) | 2026-03-31 | |
| AZN | AstraZeneca PLC | 4.51% | 456.0K | $89.9M | new | $155.46(+25.53%) | 2026-03-31 | |
| COGT | Cogent Biosciences Inc | 4.08% | 2.11M | $81.4M | +7.09%(+139.93K) | $8.75(+342.39%) | 2026-03-31 | |
| RARE | Ultragenyx Pharmaceutical Inc | 3.3% | 3.15M | $65.9M | +3676.58%(+3.06M) | $22.10(+51.48%) | 2026-03-31 | |
| RAPP | Rapport Therapeutics Inc | 2.99% | 1.90M | $59.6M | +0.00%(+0) | $23.23(+67.76%) | 2026-03-31 | |
| INSM | Insmed Inc | 2.84% | 346.1K | $56.6M | +120.71%(+189.27K) | $133.33(-16.30%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +29.20% | +115.68% |
| Top 20 Holdings Unweighted | +33.30% | +136.88% |
Sign up free to track Sofinnova Investments INC, compare funds side by side, and get alerts the moment positions change.